Literature DB >> 2173975

Stress-induced peptide release from rat intermediate pituitary. An ultrastructural analysis.

J A Carr1, L C Saland, A Samora, S Desai, S Benevidez.   

Abstract

We tested the hypothesis that acute restraint stress results in ultrastructural evidence for enhanced release of alpha-melanocyte-stimulating hormone (alpha-MSH) and beta-endorphin from the intermediate lobe (IL) of the rat pituitary. Measurements of plasma alpha-MSH- and beta-endorphin-immunoreactivity (ir) were used to confirm ultrastructural findings. Plasma alpha-MSH-ir was elevated after 20 and 30 min of restraint while plasma beta-endorphin-ir peaked 10 min after the onset of restraint. Ultrastructural analysis revealed a decrease in the content of secretory granules within IL cells of stressed rats. Analysis of Golgi-related immature secretory granules in IL cells indicated that new peptide synthesis was not enhanced after 30 min of restraint. These results confirm previous studies showing an elevation of plasma beta-endorphin and alpha-MSH-ir during acute restraint. Furthermore, these results indicate that quantitative analysis at the ultrastructural level can be used to assess peptide release from IL secretory cells during stress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173975     DOI: 10.1007/BF00313539

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  24 in total

1.  The effect of stress on the cytology and immunocytochemistry of pars intermedia cells in the rat pituitary.

Authors:  G C Moriarty; N S Halmi; M Moriarty
Journal:  Endocrinology       Date:  1975-06       Impact factor: 4.736

2.  Sympathoadrenal activity facilitates beta-endorphin and alpha-MSH secretion but does not potentiate ACTH secretion during immobilization stress.

Authors:  R Kvetnansky; F J Tilders; I D van Zoest; M Dobrakovova; F Berkenbosch; J Culman; P Zeman; P G Smelik
Journal:  Neuroendocrinology       Date:  1987-04       Impact factor: 4.914

3.  Intragranular processing of pro-opiomelanocortin in the intermediate cells of the rat pituitary glands. A quantitative immunocytochemical approach.

Authors:  M Kalina; M Elmalek; I Hammel
Journal:  Histochemistry       Date:  1988

4.  Corticotropin-releasing factor (CRF) and neurotransmitters modulate melanotropic peptide release from rat neurointermediate pituitary in vitro.

Authors:  L C Saland; L Gutierrez; J Kraner; A Samora
Journal:  Neuropeptides       Date:  1988 Aug-Sep       Impact factor: 3.286

5.  Immunocytochemical evidence for intragranular processing of pro-opiomelanocortin in the melanotropic cells of the rabbit.

Authors:  M E Stoeckel; S Schimchowitsch; J C Garaud; G Schmitt; H Vaudry; M J Klein; A Porte
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

6.  The beta-adrenoceptor-blocking drug propranolol prevents secretion of immunoreactive beta-endorphin and alpha-melanocyte-stimulating hormone in response to certain stress stimuli.

Authors:  F Berkenbosch; I Vermes; F J Tilders
Journal:  Endocrinology       Date:  1984-09       Impact factor: 4.736

7.  Effects of experimental hypo- or hypernatremia on the fine structure of the pars intermedia of the murine pituitary. A morphometric study.

Authors:  G Schmitt; M E Stoeckel; M J Klein; A Porte
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

8.  Pro-opiocortin processing in the pituitary: a model for neuropeptide biosynthesis.

Authors:  Y P Loh; H A Gritsch; T L Chang
Journal:  Peptides       Date:  1982 May-Jun       Impact factor: 3.750

9.  The effect of reserpine on the pars intermedia of the rat pituitary. An electron-microscopic, fluorescence-histochemical and immunohistochemical study.

Authors:  N Bäck; L Rechardt
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

10.  Effects of p-chloroamphetamine, a serotonin-depleting drug, on the median eminence and pituitary pars intermedia.

Authors:  L C Saland; W G Dail; E Reyes
Journal:  J Neurobiol       Date:  1980-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.